Trump Administration Reaches Deal to Lower GLP-1 Drug Prices
- On November 11, 2025
On November 6, the Trump administration announced a new agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to substantially reduce the cost of GLP-1 medications for millions of Americans.
Read More
